ID S1310

Products using ingredients or additives subjected to human fetal tissue during testing or production must include explicit labeling indicating this use

Applies to vaccinations and medical products, covering testing on final products, components, materials, or specific production lots/batches

Manufacturers face strict liability for labeling violations; retailers are liable only with actual knowledge of non-compliance

Attorney general may seek injunctive relief and civil penalties up to $5,000 per violation or 5% of gross revenue from violating product sales in Idaho

"Human fetal tissue" is defined broadly to include tissue/cells from dead embryos or fetuses, fetal cell lines, and derivative biological matter such as DNA or proteins

Effective date: July 1, 2026, with emergency declaration